Recombinant Full-Length Parathyroid Hormone (1-84): A Viewpoint by James Whitfield

By Whitfield James  

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2382-2385

Adis International

Access to resources Recommend Favorite

ALX 111: ALX1-11, Parathyroid Hormone (1-84) – NPS Allelix, PREOS™, PTH, Recombinant Human Parathyroid Hormone, rhPTH (1-84)

By Limited A.I.  

Drugs in R&D, Vol. 4, Iss. 4, 2003-01 ,pp. : 231-235

Adis International

Access to resources Recommend Favorite

Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults

By Meyer Silke   Schaefer Stephan   Stolk Lisette   Arp Pascal   Uitterlinden Andréé G   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Kann Peter H  

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1599-1608

Future Medicine

Access to resources Recommend Favorite

Use of Recombinant Human Parathyroid Hormone(1-84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain - the PROPOSE Study

By Möricke Rüdiger  

Clinical Drug Investigation, Vol. 31, Iss. 2, 2011-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Economic and Epidemiological Modelling of Full-Length Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free Method, in Previously Treated Patients with Haemophilia A: Comparison with B-Domain Deleted rFVIII, and Value of Potential Viral Transmission Reduction due to Plasma/Albumin-Free Status

By Sclar David A.   Evans Marc A.   Skaer Tracy L.   Robison Linda M.   Chung Karen C.   Poulios Nick S.  

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 149-156

Adis International

Access to resources Recommend Favorite